pirfloxacin has been researched along with ciprofloxacin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| García Sánchez, JE; García-Rodríguez, JA; Muñoz Bellido, JL; Trujillano, I | 1 |
| Artico, M; Corelli, F; Mai, A; Massa, S; Panico, S; Simonetti, N | 1 |
| Artico, M; Corelli, F; Massa, S; Panico, S; Simonetti, N; Stefancich, G | 2 |
| Coll, R; Esteve, M; Moros, M; Parés, J; Xicota, MA | 2 |
| Demestre, I; García, C; Guzmán, A | 2 |
| Demestre, I; García, C; Guzmán, A; Marín, AP; Willoughby, C | 1 |
| Lei, M; Wu, K; Xu, J; Yang, M; Yang, Y; Ye, C; Yu, M; Zhao, C | 1 |
11 other study(ies) available for pirfloxacin and ciprofloxacin
| Article | Year |
|---|---|
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
In vitro activities of irloxacin and E-3846, two new quinolones.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1990 |
Research on antibacterial and antifungal agents. XI. New antibacterial quinolones related to pirfloxacin.
Topics: Anti-Infective Agents; Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Fluoroquinolones | 1989 |
[Antibacterial and antifungal agents. VI. Pirfloxacin and related compounds: synthetic and microbiological studies].
Topics: Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Pseudomonas aeruginosa; Quinolines | 1986 |
Comparative activity of three new fluoroquinolones.
Topics: Anti-Infective Agents; Bacillus; Bacteria; Ciprofloxacin; Corynebacterium; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas; Quinolones; Staphylococcus; Streptococcus | 1987 |
In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Quinolines | 1987 |
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1H-pyrrol-1-yl)-quinoline-3-carb oxylic acid, a new fluorinated compounds of oxacin family with high broad-spectrum antibacterial activities.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Proteus; Pseudomonas aeruginosa; Quinolines | 1985 |
Acute and subchronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Body Weight; Ciprofloxacin; Dose-Response Relationship, Drug; Enzymes; Female; Fluoroquinolones; Injections, Intraperitoneal; Liver Function Tests; Male; Mice; Organ Size; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Subchronic toxicity of the new quinolone antibacterial agent irloxacin in beagle dogs.
Topics: Animals; Anti-Infective Agents; Blood Cell Count; Body Weight; Ciprofloxacin; Dogs; Electrolytes; Enzymes; Female; Fluoroquinolones; Liver; Male; Organ Size; Proteins; Sex Characteristics; Time Factors | 2000 |
Developmental toxicity studies of the quinolone antibacterial agent irloxacin in rats and rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Infective Agents; Ciprofloxacin; Embryo, Mammalian; Embryonic and Fetal Development; Female; Fluoroquinolones; Organ Size; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Teratogens | 2003 |
Experimental studies on soft contact lenses for controlled ocular delivery of pirfinedone: in vitro and in vivo.
Topics: Animals; Aqueous Humor; Biological Availability; Ciprofloxacin; Conjunctiva; Contact Lenses, Hydrophilic; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Female; Male; Ophthalmic Solutions; Polyhydroxyethyl Methacrylate; Rabbits | 2016 |